Overview (15 Sep 2021)
NGL FINE-CHEM LTD.
NGLFINE
INE887E01022

Pharmaceuticals
-7.45

Prev. Close
Previous Close
2932.7
Current Close
2925.25
Current High
2981
Current Low
2901.1
52 Week High
3464.25
52 Week Low
622.2
Resistance 1
2970.46
Resistance 2
3015.68
Support 1
2890.56
Support 2
2810.66
Std Deviation
11.81%
DMA 200
1756.22
DMA 50
2681.96
DMA 20
2978.14
Fundamentals and Ratios
Standalone
Trailing EPS
89.79
Forwad EPS
110.44
Trailing P/E
32.58
Forward P/E
26.49
PEG Ratio
1.1518
Mkt. Cap (Cr)
Market Cap (Cr)
1807.23
Total Debt(Cr)
Tot. Debt(Cr)
29.33
Reserve (Cr)
95.87
Book Value
159.61
P/BV Ratio
18.33
ROCE(%)
71.00
ROE
92.00
Consolidated
Trailing EPS
91.81
Forwad EPS
109.37
Trailing P/E
31.86
Forward P/E
26.75
PEG Ratio
1.4
Mkt. Cap (Cr)
Market Cap (Cr)
1807.23
Total Debt(Cr)
Tot. Debt(Cr)
29.33
Reserve (Cr)
95.87
Book Value
159.61
P/BV Ratio
18.33
ROCE(%)
72.00
ROE
93.00

 

Financial Result
Standalone
TypeJun-21Mar-21Dec-20Sep-20Jun-20FY20-21
Revenue75.9171.7972.7968.2142.42255.21
Other Income4.922.543.652.852.2511.52
Total Income80.8374.3276.4471.0644.68266.73
Interest0.370.330.370.540.601.84
Expenditure-55.09-53.15-53.21-51.85-32.28-190.73
PBDT0.000.000.000.000.000.00
Depreciation-1.93-1.85-1.86-1.81-1.87-7.39
PBT25.7521.1823.2319.2212.4076.00
Tax-6.40-6.87-5.72-4.42-3.52-20.53
Equity0.000.000.000.000.000.00
OPM33.9229.5031.9128.1729.2228.00
Net Profit19.3514.3117.5114.88.8755.47
NPM25.4919.9324.0621.6920.9221
EPS31.3223.1628.3523.9514.3689.79
Consolidated
TypeJun-21Mar-21Dec-20Sep-20Jun-20FY20-21
Revenue75.8671.7772.7268.3442.37257.98
Other Income4.552.303.512.772.188.02
Total Income80.4174.0776.2371.1144.55265.99
Interest0.370.330.370.540.601.84
Expenditure-54.84-53.39-52.80-50.54-31.62-188.40
PBDT0.000.000.000.000.000.00
Depreciation-2.18-2.08-2.11-2.05-2.10-8.33
PBT25.5720.6823.4320.5712.9377.59
Tax-6.44-6.84-5.72-4.76-3.54-20.87
Equity0.000.000.000.000.000.00
OPM31.8027.9230.7428.9329.0329.17
Net Profit19.1313.8417.7115.819.3956.72
NPM23.7818.6823.2322.2321.0721.32
EPS30.9622.428.6725.5915.1991.81
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2021Final Dividend1.75Dividend - Rs. - 1.750012 Aug 2021
2020Final Dividend1.75Final Dividend - Rs. - 1.750006 Aug 2020
2019Final Dividend1.75Final Dividend - Rs. - 1.750013 Aug 2019
Bonus
Split

Mutual Fund Holddings
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
AARTIDRUGS
620.35
22.44
ABBOTINDIA
21124.3
64.99
AJANTPHARM
2224.45
28.67
ALBERTDAVD
601.3
15.5
ALEMBICLTD
115.6
222.31
ALKEM
3852.15
27.33
AMBALALSA
29.55
-24.22
ANUHPHR
122.9
21.64
APLLTD
789.75
13.02
AREYDRG
37.7
13.51
ARMOURPO
235.2
26.79
ASTRAZEN
3140.4
84.15
AUROLAB
126.15
10.95
AUROPHARMA
759
14.29
BACPHAR
6.32
-15.41
12345678910
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020